D-0516-2025 Class II Ongoing
FDA drug recall D-0516-2025 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jun 16, 2025 and is designated Class II. Reason for recall: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH). The recall status is ongoing. Affected quantity: 5,448 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 23, 2025
- Initiation Date
- Jun 16, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,448 bottles
Product description
Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88
Reason for recall
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).
Distribution pattern
Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.
Code information
Lot # AD42648, Exp 02/28/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0516-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026